Attitudes and Practice of Cervical Cancer Screening among Female University Students from 25 Low, Middle Income and Emerging Economy Countries

  • Pengpid, Supa (Asean Institute for Health Development, Mahidol University) ;
  • Peltzer, Karl (Asean Institute for Health Development, Mahidol University)
  • Published : 2014.09.15


Cervical cancer, the third commonest cancer in women worldwide, can be prevented through early detection by cervical screening (Pap smear). The aim of this study was to investigate the attitudes and practice of cervical cancer screening among female undergraduate university students from 25 low, middle income and emerging economy countries. Using anonymous questionnaires, data were collected from 9,194 female undergraduate university students aged 18-26 years (mean age 20.9, SD=2.0) from 26 universities in 25 countries across Asia, Africa and the Americas. Overall, 11.6% of the female students indicated that they had conducted one or more times a cervical (Pap) smear test; 8.3% among 18-20 year-olds and 15.6% among 21-26 year-old students. There was considerable country variation on having had a cervical (Pap) smear test among 21-26 year-old female university students, ranging from 59.2% in Colombia and 50.9% in Barbados to 0% in India and 1.0% in Tunesia. Logistic regression showed that cervical cancer screening importance or positive attitude were highly associated with the cervical screening practice. Moreover, risky sexual behaviour and tobacco use, two cervical cancer risk factors, were associated with screening. Cervical cancer screening practices were found to be inadequate and e fforts should be made to develop programmes that can increase the uptake of cervical cancer screening.


  1. Abotchie PN, Shokar NK (2009). Cervical cancer screening among college students in Ghana: knowledge and health beliefs. Int J Gynecol Cancer, 19, 412-6.
  2. Akujobi CN, Ikechebelu JI, Onunkwo I, Onyiaorah IV (2008). Knowledge, attitude and practice of screening for cervical cancer among female students of a tertiary institution in South Eastern Nigeria. Niger J Clin Pract, 11, 216-9.
  3. Al-Naggar RA, Low WY, Isa ZM (2010). Knowledge and barriers towards cervical cancer screening among young women in Malaysia. Asian Pac J Cancer Prev, 11, 867-73.
  4. Aniebue PN, Aniebue UU (2010). Awareness and practice of cervical cancer screening among female undergraduate students in a Nigerian university. J Cancer Educ, 25, 106-8.
  5. Ayinde OA, Omigbodun AO, Ilesanmi AO (2004). Awareness of cervical cancer, papanicolaou's smear and its utilisation among female undergraduates in Ibadan. Afr J Reprod Hlth, 8, 68-80.
  6. Bakogianni GD, Goutsou SC, Liti MV, et al (2012). Knowledge, attitude, and practice of cervical cancer screening among Greek students: a short report. Int J Adolesc Med Health, 24, 329-30.
  7. Botha H, Cooreman B, Dreyer G, et al (2010). Cervical cancer and human papillomavirus: South African guidelines for screening and testing. South Afr J Gynaecol Oncol, 2, 23-26.
  8. Chou P (1991). Review on risk factors of cervical cancer. Zhonghua Yi Xue Za Zhi, 48, 81-8.
  9. Dhendup T, Tshering P (2014). Cervical cancer knowledge and screening behaviors among female university graduates of year 2012 attending national graduate orientation program, Bhutan. BMC Womens Health, 14, 44.
  10. Durvasula RS, Regan PC, Ureno O, Howell L (2006). Frequency of cervical and breast cancer screening rates in a multi-ethnic female college sample. Psychol Rep, 99, 418-20.
  11. Ghojazadeh M, Azar ZF, Saleh P, Naghavi-Behzad M, Azar NG (2012). Knowledge and attitude of Iranian University students toward human papilloma virus. Asian Pac J Cancer Prev, 13, 6115-9.
  12. Ghotbi N, Anai A (2012). Assessment of the knowledge and attitude of female students towards cervical cancer prevention at an international university in Japan. Asian Pac J Cancer Prev, 13, 897-900.
  13. Globocan (2012). Estimated cancer incidence, mortality and prevalence worldwide in 2012. Available at:, accessed 25 May 14.
  14. Hoque ME (2013). Awareness of cervical cancer, Papanicolau's smear and its utilization among female, final year undergraduates in Durban, South Africa. J Cancer Res Ther, 9, 25-8.
  15. Hoque ME, Ghuman S, Hal GV (2013). Human papillomavirus vaccination acceptability among female university students in South Africa. Asian Pac J Cancer Prev, 14, 4865-9.
  16. Lu M, Moritz S, Lorenzetti D, et al (2012). A systematic review of interventions to increase breast and cervical cancer screening uptake among Asian women. BMC Public Health, 12, 413.
  17. Murthy NS, Mathew A (2000). Risk factors for pre-cancerous lesions of the cervix. Eur J Cancer Prev, 9, 5-14.
  18. Oladepo O, Ricketts OL, John-Akinola Y (2008/9). Knowledge and utilization of cervical cancer screening services among Nigerian students. Int Q Community Health Educ, 29, 293-304.
  19. Oshima S, Maezawa M (2013). Perception of cervical cancer screening among Japanese university students who have never had a pap smear: a qualitative study. Asian Pac J Cancer Prev, 14, 4313-8.
  20. Pan American Health Organization (2013). Situational analysis of cervical cancer prevention and control in the Caribbean: Results from a 2013 assessment of country policies and services for HPV vaccination, cervical cancer screening, diagnosis and treatment.
  21. Peirson L, Fitzpatrick-Lewis D, Ciliska D, Warren R (2013). Screening for cervical cancer: a systematic review and metaanalysis. Syst Rev, 2, 35.
  22. Rashwan HH, Saat NZ, Abd Manan DN (2012). Knowledge, attitude and practice of Malaysian medical and pharmacy students towards human papillomavirus vaccination. Asian Pac J Cancer Prev, 13, 2279-83.
  23. The United States Preventive Services Task Force (USPSTF, 2012). Screening for Cervical Cancer: Clinical Summary of U.S. Preventive Services Task Force Recommendation. AHRQ Publication No. 11-05156-EF-3, March 2012. Available at:
  24. Wardle J, Steptoe A (1991). The European Health and Behaviour Survey: rationale, methods and initial results from the United Kingdom. Soc Sci Med, 33, 925-36.
  25. World Health Organization (WHO) (2008). Guidelines for controlling and monitoring the tobacco epidemic. Geneva: WHO.
  26. World Health Organization (WHO) (2013). WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. Geneva, Switzerland: WHO.

Cited by

  1. Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective vol.16, pp.1, 2016,
  3. Avaliação da não realização do exame Papanicolaou por meio do Sistema de Vigilância por inquérito telefônico vol.52, pp.0, 2018,
  4. Cervical Cancer Screening Beliefs and Prevalence of LSIL/HSIL Among a University-Based Population in Cameroon vol.22, pp.4, 2018,